Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arthrocentesis vs Botox for TMJ Disorders
NCT07736521Not yet recruiting
- Sponsor
- Mudher MB Alsunbuli
- Start
- Aug 2026
- Primary completion
- Nov 2026
01
Overview
Randomised trial of botulinum toxin type A in temporomandibular joint disorder (TMJ) (2 arms), sponsored by Mudher MB Alsunbuli. Primary endpoint: Change in Pain Intensity Measured by Visual Analog Scale at 6 months. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular joint disorder (TMJ)
Beyond the preview
Go deeper on NCT07736521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07736521.